SCHEMBL31661173

SCHEMBL31661173

COC(=O)C1COc2c1cccc2N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
GPR119 Q8TDV5 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
NAMPT P43490 1/20 0.41
BACE1 P56817 4/20 0.40
MAPK8 P45983 1/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
TP53 P04637 1/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
CKS1B P61024 1/20 0.39
SKP1 P63208 1/20 0.39
SKP2 Q13309 1/20 0.39
STS P08842 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661184 0.81 MAPT (0.47) ALDH1A1GPR119MAPTLMNANAMPT
SCHEMBL31661161 0.79 GPR119 (0.39) ALDH1A1GPR119MAPTLMNAPTPN2
SCHEMBL21198677 0.75 ADRB1 (0.52) ALDH1A1LMNAMAPK1
SCHEMBL12478533 0.75 DRD2 (0.50)
SCHEMBL5366208 0.74 NAMPT (0.47) ALDH1A1GPR119MAPTLMNANAMPT
SCHEMBL5369055 0.72 HTR1A (0.46) ALDH1A1GPR119MAPTLMNANAMPT
SCHEMBL1439591 0.72 GPR119 (0.44) ALDH1A1GPR119MAPTLMNANAMPT
SCHEMBL23980816 0.72 MEN1 (0.47) BACE1STSHTT
SCHEMBL114482 0.71 GPR119 (0.53) ALDH1A1GPR119MAPTLMNAPTPN2
SCHEMBL30659464 0.71 MAPK1 (0.50) ALDH1A1GPR119MAPTLMNANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151602-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2025-07-17 WO disclosed